Skip to content

Gonadal Function in Young to Middle Aged HIV-infected Men

Gonadal Function in Young to Middle Aged HIV-infected Men Assessed by Isotopic Dilution-liquid Chromatography-mass Spectrometry (ID-LC-MS/MS) and Chemiluminescent Immunoassay

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03747003
Enrollment
315
Registered
2018-11-20
Start date
2013-05-15
Completion date
2018-12-31
Last updated
2021-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erectile Dysfunction, Human Immunodeficiency Virus, Hypogonadism, Male

Brief summary

HIV infection is associated to premature decline of serum testosterone. However, prevalence and biochemical characterization of hypogonadism in HIV-infected men are still to be well defined. HIV-infection is strongly associated to erectile dysfunction in men, but preliminary data suggest that it is poorly associated with serum testosterone in this context.

Detailed description

The aim of this study is to evaluate the gonadal function of young to middle aged HIV-infected men in order to characterize hypogonadism by assessing circulating total testosterone with either Liquid Chromatography tandem Mass Spectrometry (LC-MS/MS) or chemiluminescent immunoassay. Furthermore, secondary aim is to assess the erectile function through the use of validated questionnaires (International Index of Erectile Function (IIEF) 15 and 5).

Interventions

No intervention is provided

Sponsors

Azienda Ospedaliero-Universitaria di Modena
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Male gender * Age 18-50 years * HIV-infection * Ongoing Highly Active Antiretroviral Therapy

Exclusion criteria

* Previous treatment with androgens, anti-androgens * Severe liver insufficiency * Severe renal insufficiency

Design outcomes

Primary

MeasureTime frameDescription
Serum total testosteroneAssessed only once at the moment of enrollment with liquid chromatography tandem mass spectrometryFrom blood sample - unit of measurement ng/dL

Secondary

MeasureTime frameDescription
Serum free testosteroneCalculated only once at the moment of enrollmentCalculated formula (Vermeulen equation)
Score at IIEF questionnaireAssessed only once at the moment of enrollmentTotal score at erectile function domain of IIEF-15 questionnaire

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026